looks a decent long term play, seasonal business though as highlighted in the presentation.. so dont expect next half to be as strong.. but they should hit guidance.. will be a slow mover by the looks a good buy for the patient
ATL Price at posting:
$1.42 Sentiment: None Disclosure: Held